Introduction
============

*Candida albicans* is the major pathogen that causes hospital-acquired fungal infections in humans ([@b1-mmr-18-02-2017]). *C. albicans* is an opportunistic pathogen, which is commonly found on the skin and in the urogenital tract of humans ([@b2-mmr-18-02-2017]). Alterations in host immunity, stress, resident microbiota and other factors can induce the overgrowth of *C. albicans*, thus resulting in a wide range of infections, including superficial mucosal and hematogenously disseminated candidiasis ([@b3-mmr-18-02-2017]). In addition, the widespread use of antifungal agents has resulted in the emergence of drug-resistant *C. albicans* among previously drug-susceptible populations ([@b4-mmr-18-02-2017]). Research within the previous few decades has identified numerous drug resistance mechanisms. One of the main factors resulting in drug tolerance is adaptive flexibility to different environments via adherence to a surface and growth in microbial populations, which is known as biofilm development ([@b2-mmr-18-02-2017],[@b5-mmr-18-02-2017]). In general, *C. albicans* biofilm formation is characterized by four stages: i) Cell-wall protein-mediated adherence of cells to a surface; ii) growth of the cells into a thin layer; iii) biofilm maturation via development of pseudohyphae and hyphae, and excretion of matrix material; and iv) finally, dispersal of cells from the biofilm, which may lead to colonization of new surfaces ([@b6-mmr-18-02-2017]--[@b9-mmr-18-02-2017]). The clinical treatment of *C. albicans* infection has become more difficult with the emergence of biofilms, as *C. albicans* cells present in biofilms are highly resistant to antifungal agents, including fluconazole, nystatin, amphotericin B and chlorhexidine ([@b10-mmr-18-02-2017]). Therefore, there is an urgent requirement for the development of novel antifungal therapies.

In recent years, phototherapy has been suggested to represent a potential therapeutic alternative to antifungal treatment for the treatment of *C. albicans* biofilm infections. In addition, numerous studies have demonstrated that light with a wavelength of 400--500 nm, namely blue light (BL), exhibits marked antimicrobial effects against methicillin-sensitive *Staphylococcus aureus*, methicillin-resistant *Staphylococcus aureus* (MRSA), *Escherichia coli, Pseudomonas aeruginosa* and *Acinetobacter baumannii* ([@b11-mmr-18-02-2017]--[@b20-mmr-18-02-2017]). However, at present, there is insufficient evidence to demonstrate that BL induces *C. albicans* cell death within the biofilm matrix. Considering the increasing emergence of antimicrobial-resistant microorganisms, BL may represent a novel antimicrobial therapeutic agent. BL results in bacterial cell death and exhibits far fewer adverse side effects to host cells and tissues compared with ultraviolet light, and it does not require the use of additional exogenous photosensitizers ([@b15-mmr-18-02-2017]). However, the bactericidal mechanism of BL is still not fully understood. One particularly well-established hypothesis regarding the bactericidal mechanism of BL is that BL excites endogenous intracellular porphyrins of bacteria, resulting in production of cytotoxic reactive oxygen species that can kill bacterial cells ([@b21-mmr-18-02-2017]--[@b23-mmr-18-02-2017]).

In order to determine the effects of 460 nm BL irradiation on *C. albicans* infection, the present study aimed to investigate the efficacy of BL treatment on planktonic and biofilm *C. albicans* infection *in vitro* and in a mouse skin wound infection model *in vivo*. The results demonstrated that irradiation with BL effectively eradicated planktonic and biofilm *C. albicans* infections in a dose-dependent manner. In addition, the results revealed that BL exhibited a therapeutic effect on wounds infected with *C. albicans* in mice via induction of cell death.

Materials and methods
=====================

### Light source

The BL source used in the present study was a 6.25 cm^2^ cluster of 50 light emitting diode (LED) array (Lifotronic Technology Co., Ltd., Shenzhen, China), which emitted light at a 450--470 nm spectral width and 460 nm peak emission ([Fig. 1](#f1-mmr-18-02-2017){ref-type="fig"}). Irradiance of light was adapted via adjustment of the distance between the LED array aperture and the *C. albicans*, which was determined using a power meter FieldMaxII-TO (RoHS) system (Coherent Inc., Santa Clara, CA, USA). The red-light source with a 620--640 nm spectral width was purchased from Lifotronic Technology Co., Ltd.

### Light exposure

The LED array was positioned 10 cm perpendicularly above each uncovered plate or wound to ensure accurate irradiation of each sample. The fluencies used are presented in [Table I](#tI-mmr-18-02-2017){ref-type="table"}. A small fan was used to prevent heat accumulation during the irradiation process and the temperature on the surface of the organisms was measured every 1 min using an infrared thermometer.

### Fungal strain and cultivation

The pathogenic strain, *C. albicans* ATCC 10231 was purchased from Shanghai Beinuo Life Science Bio Technology Co. Ltd. (Shanghai, China). The strain was identified by standard procedures, including gram stain and cell morphology, colony description, purity, viability and genotypic testing. The *C. albicans* strain was cultured overnight at 37°C under aerobic conditions with Sabouraud dextrose medium (Qingdao Hope bio-Technology Co., Ltd., Qingdao, China). Subsequently, *C. albicans* cells were inoculated in Sabouraud dextrose liquid medium at 37°C and were maintained in an orbital shaker at 150 rpm until the cells reached an optical density of 1.0 at 600 nm, which was equivalent to \~10^8^ CFU/ml. Following this, the suspension was centrifuged at 300 × g and 37°C for 5 min, washed with PBS and diluted to 10^7^ CFU/ml for subsequent analysis.

### BL eradication of planktonic C. albicans in vitro

The spread plate method was used to investigate the antifungal effect of BL. *C. albicans* suspension (10 µl; \~10^5^ CFU/ml) was evenly spread on Sabouraud dextrose medium plates. Uncovered plates containing *C. albicans* were subsequently subjected to irradiation using BL LED array or red-light LED array (energy densities, 0, 12, 60, 120 and 240 J/cm^2^). Subsequently, the plates were permitted to grow in a 37°C incubator for 24 h, after which images of each plate were captured and the number of colonies present was counted. The experiments were performed independently and in triplicate.

Flow cytometry was also used to determine the antifungal effects of BL. Using a micropipette, 1×10^7^ CFU/ml *C. albicans* suspension (50 µl) in PBS was added to each well of a 24-well plate. Subsequently, the plates were irradiated using 0 or 240 J/cm^2^ energy density of BL or red light. *C. albicans* cells were subsequently stained using propidium iodide (PI; 100 µg/ml) for 25 min at room temperature and detected via flow cytometry. PI staining was used to investigate the number of dead cells, as it can enter membrane-damaged cells. The mortality rate of *C. albicans* was determined using the formula: Mortality rate=(number of cells in the R2 region/number of cells in the R1 region) ×100%. Data were analyzed using WinMDI software (version 2.9; The Scripps Research Institute, La Jolla, CA, USA). Experiments were repeated independently and in triplicate.

### Phototoxicity assay using human skin fibroblasts and keratinocytes

Human skin fibroblast (HSF) Hs27 cells were purchased from Shanghai Bioleaf Biotech (Shanghai, China) and were cultured in petri dishes (diameter, 10 cm) supplemented with Dulbecco\'s modified Eagle\'s medium (Hyclone, USA) and 10% fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) at 37°C in a 5% CO~2~ incubator. HaCaT cells were purchased from the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (Beijing, China) and were cultured in petri dishes (diameter, 10 cm) with serum-free keratinocyte medium and phenol red, supplemented with recombinant epidermal growth factor (5 µg/ml) and bovine pituitary extract (50 µg/ml; all Gibco; Thermo Fisher Scientific, Inc.) at 37°C in a 5% CO~2~ incubator. The growth medium was replaced with fresh medium every 2--3 days. Once a confluence of 80% was reached, the cells were trypsinized. Subsequently, the cell suspension was centrifuged at 300 × g and 37°C for 5 min and the cell pellet was resuspended in PBS. The HSF cell suspension (100 µl) and HaCaT cell suspension (100 µl) containing 1×10^6^ cells/ml in media were added to 96-well plates and incubated overnight at 37°C. The 16 wells of a 96-well plate were separated into a light treatment group (8 wells) and a control group (8 wells). The wells in the light treatment group were subjected to irradiation with 240 J/cm^2^ BL. The wells in the control group were not subjected to any treatment. Following this, 100 µl fresh medium containing 10 µl water-soluble tetrazolium salt \[Cell Counting kit-8 (CCK-8); Dojindo Molecular Technologies, Inc., Kumamoto, Japan\] was added and incubated at 37°C for 2 h in the dark. The absorbance was measured at 450 nm using an Infinite M200 Pro multifunctional microplate reader (Tecan Group, Ltd., Männedorf, Switzerland). Experiments were performed in triplicate.

### Establishment of a C. albicans biofilm model

A *C. albicans* biofilm model was established using the method described by Ramage *et al* ([@b24-mmr-18-02-2017]), with slight modifications. Using a micropipette, 1×10^7^ CFU/ml *C. albicans* (500 µl) and Sabouraud dextrose medium (2.5 ml) were added to laser confocal special culture plates (Cellvis, Mountain View, CA, USA). The plate was incubated at 37°C with 120 rpm agitation for 100 min. Following cell adhesion, the medium was aspirated, non-adherent cells were removed and 2.5 ml fresh medium was added. The plate was further incubated at 37°C for 3 days. The medium was replaced with fresh medium every 24 h. Following the removal of culture medium, biofilm formation was observed under an optical microscope (Nikon Corporation, Tokyo, Japan), and images were captured at 1, 2 and 3 day time intervals.

### Irradiation of BL on C. albicans biofilm in vitro

Following culture for 3 days, *C. albicans*-exhibiting mature biofilms were divided into a control group and a light group. The control group was not subjected to any treatment, whereas the light group was subjected to irradiation using 240 J/cm^2^ BL. Following this, the two groups were stained using a LIVE/DEAD^®^ *Fungal* Light™ Yeast Viability kit (Invitrogen; Thermo Fisher Scientific, Inc.) at room temperature for 30 min in the dark. The kit contained solutions of SYTO^®^ 9 green-fluorescent nucleic acid stain and PI red-fluorescent nucleic acid stain. These stains differ both in their spectral characteristics as well as their ability to penetrate healthy cells. As a result, *C. albicans* with intact membranes were stained fluorescent green, whereas cells with damaged membranes were stained fluorescent red. The antifungal effect of BL was observed using a confocal laser scanning microscope (LSM 510; Zeiss GmbH, Jena, Germany). Images were acquired using an EC Plan-Neofluar 40×/1.30 Oil DIC M27 objective, and 488 and 555 nm laser lines for excitation of Live/Dead stain.

### Establishment of mouse models bearing skin wounds infected with C. albicans

Animal experiments were approved by the Committee on Research Animal Use of Shanghai Jiao Tong University (Shanghai, China) and were performed in accordance with National Institutes of Health guidelines ([@b25-mmr-18-02-2017]). A total of 30 adult female BALB/c nude mice (6--8 weeks old, 15--20 g) were purchased from the Experimental Animal Center at The Second Military Medical University (Shanghai, China) and were maintained under a 12-h light/dark cycle at room temperature and 40--60% relative humidity. Standard complete nutritional feeds were sterilized and drinking water was filtered to remove bacteria. Mice were able to eat, drink and move freely in a sterile isolation chamber. Mice were administered an intraperitoneal injection of 1% pentobarbital sodium (75 mg/kg; Sinopharm Chemical Reagent Co. Ltd., Shanghai, China) prior to inoculation with *C. albicans* on day 0. Following disinfection using 75% alcohol, 1.0 cm^2^ full-thickness abrasions were made on the back surface of each mouse. A total of 30 mice were randomly divided into three groups, including: Negative control group \[*C. albicans* (−); BL (−)\], positive control group \[*C. albicans* (+); BL (−)\] and the light treatment group \[*C. albicans* (+), BL (+)\]. A total of 10 min following wound induction, the wound surfaces of mice in the positive control group and the light treatment group were treated with 20 µl suspension containing 10^9^ CFU/ml of *C. albicans* by evenly smearing the suspension onto the wound surface using an inoculation loop. The skin wound was covered with sterile gauze and bound up with 3M surgical dressing to avoid scratching or chewing by the animal. A single cage was kept for each mouse. A technician monitored the mice every hour and they did not exhibit any pain or discomfort. Thus, we did not use extra drugs such as anesthetics for the mice following the wound formation.

### Treatment with BL for skin wounds infected with C. albicans in a mouse model

Mice in the light treatment group were subjected to irradiation once a day using 240 J/cm^2^ BL at 0, 1 and 2 day time intervals. The negative control group and the positive control group were not subjected to any treatment. At 0, 1, 2 and 3 days post-irradiation, the secreta on the wound surfaces of all of the mice were collected using sterile swabs and then smeared on the surface of Sabouraud Dextrose Agar Medium plates using a sterile inoculation loop prior to BL treatment. Plates were subsequently incubated for 24 h at 37°C, after which the number of colonies present on each plate was determined. Skin wounds were covered with sterile gauze and bound with 3M surgical dressing that was punched with a sterile needle for air circulation.

### Hematoxylin and eosin (H&E) staining of wound tissue

In order to observe histological alterations of the wound tissues in mice during the process of wound healing, three skin samples from wounds of mice in each group were obtained 7 days post-injury. The skin samples were fixed in 4% paraformaldehyde for 24 h at room temperature, embedded in paraffin and then cut into 4 µm sections. Sections were then stained using 5 µg/ml H&E at room temperature for 10 min; the results of which were observed and images were captured under an optical microscope (Nikon Corporation).

### Wound healing measurement

The skin abrasion area of each mouse was monitored and images were captured using a digital camera at 0, 3, 7, 10 and 14 days post-injury. The average duration of time taken for wound healing, as well as the percentage of the unhealed wound, were calculated to determine the healing speed of the mouse skin wound using the following formula: % of unhealed wound=(unhealed area at each time interval/total wound area at the 0 day time interval) ×100%.

### Statistical analysis

All results are presented as the means ± standard deviation and are the results of experiments repeated three times. Statistical analysis was performed using GraphPad Prism 7.0 software (GraphPad Software, La Jolla, CA, USA). Data were analyzed using either the Student\'s t-test or one-way analysis of variance followed by Student-Newman-Keuls test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### BL eradicates planktonic C. albicans in vitro

Using the spread plate method, the viability of planktonic *C. albicans* cells in the presence or absence of BL was determined. As revealed in [Fig. 2A and B](#f2-mmr-18-02-2017){ref-type="fig"}, the colony count of *C. albicans* was significantly decreased following treatment with BL (≥60 J/cm^2^) in a dose-dependent manner compared with *C. albicans* treated with red light. Irradiation with BL almost completely eradicated *C. albicans* colonies when the light fluence was 240 J/cm^2^. Furthermore, flow cytometry was used to further investigate the viability of *C. albicans* treated with or without BL. Furthermore, the flow cytometry results revealed that *C. albicans* treated with BL exhibited a significantly increased killing rate compared with *C. albicans* treated with red light (P\<0.01; [Fig. 2C and D](#f2-mmr-18-02-2017){ref-type="fig"}). In addition, quantitative analysis of these results demonstrated that the killing rates of *C. albicans* exposed to 0 and 240 J/cm^2^ BL were 7.68±0.43 and 88.92±2.01% (P\<0.01; [Fig. 2D](#f2-mmr-18-02-2017){ref-type="fig"}), respectively.

In order to determine whether 240 J/cm^2^ BL induces phototoxicity in normal cutaneous cells, the cell viabilities of HSF and HaCaT cells following BL irradiation with 240 J/cm^2^ were investigated using a CCK-8 kit. As revealed in [Fig. 2E and F](#f2-mmr-18-02-2017){ref-type="fig"}, no marked differences in the morphology and cell viabilities of HSF and HaCaT cells were revealed (P\>0.05).

### BL eradicates C. albicans inside biofilms

In order to determine whether BL can eradicate *C. albicans* within biofilms, a *C. albicans* biofilm model was established ([Figs. 3](#f3-mmr-18-02-2017){ref-type="fig"} and [4](#f4-mmr-18-02-2017){ref-type="fig"}). As revealed in [Fig. 3A](#f3-mmr-18-02-2017){ref-type="fig"}, *C. albicans* biofilm formation can be categorized into three distinct developmental phases: Early (D1; 0--24 h), intermediate (D2; 24--48 h) and maturation (D3; 48--72 h). *C. albicans* communities were completely encased within extracellular material during the maturation stage.

The present results demonstrated that irradiation with BL at 240 J/cm^2^ induced mortality of *C. albicans* cells inside the biofilm, as seen by increased red color in the light group ([Fig. 4](#f4-mmr-18-02-2017){ref-type="fig"}), whereas the vast majority of fungi in the blank control group were alive ([Fig. 3B](#f3-mmr-18-02-2017){ref-type="fig"}) as revealed by confocal laser scanning microscopy. These results suggested that BL irradiation can eradicate *C. albicans* inside biofilms.

### BL significantly suppresses C. albicans infection in vivo

Using *C. albicans*-infected skin wounds in a mouse model, the effects of BL on *C. albicans* infection were investigated. As revealed in [Fig. 5A](#f5-mmr-18-02-2017){ref-type="fig"}, the number of *C. albicans* colonies grown from *in vivo* swabs following treatment with 240 J/cm^2^ BL was markedly decreased compared with in the positive control group at day 1. In addition, the number of *C. albicans* colonies grown from *in vivo* swabs following treatment with 240 J/cm^2^ BL markedly decreased in a time-dependent manner, resulting in almost no visible *C. albicans* colonies at the 3 day time interval ([Fig. 5A](#f5-mmr-18-02-2017){ref-type="fig"}).

In general, the infiltration of inflammatory cells was associated with infection severity ([@b26-mmr-18-02-2017]). The infiltration of inflammatory cells into the wounds of mice in the three groups was investigated using H&E staining. As presented in [Fig. 5B](#f5-mmr-18-02-2017){ref-type="fig"}, large numbers of inflammatory cells were revealed to have infiltrated into skin tissue in the positive control group compared with in the negative control group and the BL light-treated group at the 7 day time interval. These results suggested that treatment with BL may protect tissues from infection with *C. albicans* in mice skin wounds.

### Treatment with BL promotes healing of infected skin wounds in mice

In order to determine whether BL affected the wound-healing process following infection with *C. albicans*, a murine skin wound infection model was established in mice, and wound-healing rates were determined. The wound-healing rates in BL-treated mice infected with *C. albicans* and in the negative control group were significantly increased compared with in the non-treated mice infected with *C. albicans* at 3, 7, 10 and 14 days (P\<0.05 and P\<0.01; [Fig. 6A and B](#f6-mmr-18-02-2017){ref-type="fig"}). The average wound closure time for the negative control group, the positive control group and BL-treated mice infected with *C. albicans* were 15.9±0.94, 18.3±1.49, and 15.2±1.08, respectively ([Fig. 6C](#f6-mmr-18-02-2017){ref-type="fig"}). These results demonstrated that irradiation with BL on *C. albicans*-infected wounds accelerated wound closure compared with in the positive control group. However, no significant differences in entire wound closure time were exhibited between BL-treated mice infected with *C. albicans* and the negative control group (P\>0.05; [Fig. 6C](#f6-mmr-18-02-2017){ref-type="fig"}).

Discussion
==========

There has been a steady increase in the incidence of fungal infections over the past several decades, and only a limited number of effective antifungal drugs remain available for treatment ([@b27-mmr-18-02-2017]). Furthermore, the incidence of resistance to antifungal drugs is also increasing ([@b28-mmr-18-02-2017]); therefore, there is a requirement for the development of novel therapeutic strategies for the treatment of fungal infections. In the present study, the antifungal effects of irradiation with BL on *C. albicans* were investigated. *C. albicans* represents the most common fungal infection; in the present study, *C. albicans* was cultured *in vitro* and inoculated in mice wounds. Firstly, the results demonstrated that BL effectively eradicated planktonic *C. albicans* in a dose-dependent manner, which was in agreement with the findings of Zhang *et al* ([@b20-mmr-18-02-2017]). To the best of our knowledge, the present study is the first to demonstrate that irradiation with 460 nm BL may increase eradication of *C. albicans* inside biofilms. Finally, the results revealed that irradiation with BL increased wound healing rates in mice, which may be due to the eradication of *C. albicans* in mouse skin wounds. Therefore, the results suggested that BL may represent a novel antifungal therapeutic strategy.

Numerous studies have demonstrated that photodynamic therapy (PDT) effectively eradicates fungi ([@b29-mmr-18-02-2017]--[@b31-mmr-18-02-2017]). However, the necessary introduction of a photosensitizer into the targeted fungi ([@b32-mmr-18-02-2017]) and into the infected tissues ([@b33-mmr-18-02-2017]) represents a major disadvantage of PDT. In recent years, BL has gained increasing attention due to its intrinsic antimicrobial effect without the addition of an exogenous photosensitizer ([@b11-mmr-18-02-2017]--[@b20-mmr-18-02-2017]). Guffey and Wilborn ([@b18-mmr-18-02-2017]) revealed that irradiation with 405 and 470 nm BL induces bactericidal effects on *Pseudomonas aeruginosa* and *Staphylococcus aureus* in a dose-dependent manner; however, BL has no effect on *Propionibacterium acnes* infection *in vitro* ([@b18-mmr-18-02-2017]). Dai *et al* ([@b15-mmr-18-02-2017]) demonstrated that BL exhibits a broad-spectrum antimicrobial effect against both gram-positive and gram-negative bacteria. The effective induction of bacterial cell death by BL has been well established; however, very few studies have investigated the effects of BL on fungi. In the present study, a wavelength of 460 nm BL was used to eradicate *C. albicans in vitro*, which was similar to the wavelength used by Zhang *et al* ([@b20-mmr-18-02-2017]). The results of the present study revealed that 68.21±2.10 and 99.92±0.14% of *C. albicans* were eradicated by 60 and 240 J/cm^2^ of BL, respectively.

Biofilms are the communities of microorganisms that develop on living or inert surfaces and are enclosed within extracellular matrixes, which form complex three-dimensional structures ([@b16-mmr-18-02-2017],[@b33-mmr-18-02-2017]). The present study, as well as previous studies ([@b16-mmr-18-02-2017],[@b19-mmr-18-02-2017]), revealed that the biofilm matrix is almost transparent; therefore, light can penetrate through the transparent biofilm. Halstead *et al* ([@b16-mmr-18-02-2017]) investigated treatment with 400 nm BL against bacteria in planktonic and biofilm growth modes *in vitro*. Our previous study demonstrated that 460 nm BL markedly eradicates planktonic and biofilm MRSA *in vitro* and *in vivo* in a dose-dependent manner ([@b19-mmr-18-02-2017]). Therefore, the aim of the present study was to determine whether BL can also eradicate *C. albicans* in biofilms. Among the fungal pathogens that can infect humans, *C. albicans* is the species most frequently associated with biofilm formation and has high morbidity and mortality rates ([@b34-mmr-18-02-2017]). Similar to bacterial biofilms, biofilm-grown *C. albicans* cells are highly resistant to antimicrobials ([@b34-mmr-18-02-2017]). In order to investigate the effects of BL on *C. albicans* inside biofilms, a *C. albicans* biofilm model was established according to the method described by Ramage *et al* ([@b24-mmr-18-02-2017]), with slight modifications. Using this model, it was revealed that *C. albicans* was able to form mature biofilms within 3 days. In addition, the results of the present study revealed that *C. albicans* within biofilms was markedly eradicated by 240 J/cm^2^ BL irradiation and the complex structures of the biofilm were destroyed. To the best of our knowledge, this is the first study to demonstrate that irradiation with BL may significantly eradicate *C. albicans* inside biofilms and this was also the main difference between our study and other studies on the BL inactivation of *C. albicans*. This result may be due to the ability of BL to penetrate through the transparent biofilm. In the present study, the inhibition of *C. albicans* infection following irradiation with 460 nm BL was further investigated using *C. albicans*-infected skin wounds in a mouse model. The amount of *C. albicans* present in wounds treated with one exposure of 240 J/cm^2^ BL was significantly suppressed compared with in the *C. albicans*-infected group. Furthermore, multiple treatments (240 J/cm^2^ per day, for 3 days) with BL revealed that treatment enhanced the eradication of *C. albicans* in a dose-dependent manner. In addition, the results of the present study revealed that BL decreased numbers of inflammatory cells in skin tissue and promoted wound healing *in vivo*. The results of the present study were in agreement with the *in vivo* results revealed by Zhang *et al* ([@b20-mmr-18-02-2017]). However, Zhang *et al* ([@b20-mmr-18-02-2017]) used a single exposure of 415 nm BL with a markedly higher dose (432 J/cm^2^), which was able to significantly reduce the fungal burden in infected mouse wounds ([@b20-mmr-18-02-2017]). This difference may due to different apparatus used.

In conclusion, the results of the present study may aid the development of novel therapeutic strategies for the treatment of *C. albicans* wound infections. Future studies should perform experiments using large animal models, as well as human trials, to verify the results of the present study. In addition, despite BL exhibiting a therapeutic effect against *C. albicans*, the specific mechanism underlying this effect remains unclear. Dai *et al* ([@b15-mmr-18-02-2017]) suggested that the mechanism of BL eradication of *P. acnes, Helicobacter pylori* and some oral bacteria involves the photo-excitation of intracellular porphyrins and the subsequent production of cytotoxic reactive oxygen species. Our previous study demonstrated that BL irradiation eradicates MRSA via induction of prophage activation ([@b19-mmr-18-02-2017]). However, the molecular mechanisms underlying the eradication of *C. albicans* by BL require further investigation.
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![Emission spectrum of blue light.](MMR-18-02-2017-g00){#f1-mmr-18-02-2017}

![Effects of BL on planktonic *C. albicans*, and HSF and HaCaT cells *in vitro*. (A) Spread plate method was used to investigate the effects of BL (0, 12, 60, 120 and 240 J/cm^2^) and red light irradiation, the results of which were (B) quantitatively analyzed. (C) Flow cytometry was performed to investigate the effects on *C. albicans* following irradiation with 240 J/cm^2^ BL and red light. R1 represents the total number of *C. albicans* cells and R2 represents the total number of dead *C. albicans* cells stained by PI, the results of which were (D) quantitatively analyzed. (E) Cell morphology of HSF and HaCaT cells following irradiation with 240 J/cm^2^ BL. Scale bar, 100 µm. (F) Quantitative analysis of cell viability of HSF and HaCaT cells following irradiation with 240 J/cm^2^ BL as determined by Cell Counting kit-8 assays. \*\*P\<0.01. BL, blue light; *C. albicans, Candida albicans*; HSF, human skin fibroblast; PI, propidium iodide.](MMR-18-02-2017-g01){#f2-mmr-18-02-2017}

![Effects of blue light on *C. albicans* inside biofilms. (A) Optical microscope images of *C. albicans* biofilms grown in the wells of plates. D1 represents the early phase, D2 represents the intermediate phase and D3 maturation phase of *C. albicans* biofilm formation. (Magnification, ×100; scale bars, 100 µm). (B) Distribution of the dead/viable *C. albicans* in the biofilm of the control group as observed by confocal laser scanning microscopy (Magnification, ×400; scale bars, 50 µm). Green staining indicates live *C. albicans*, and red staining indicates dead *C. albicans*. Images 1--15 represent scanning images from the deepest layer of the biofilm to the superficial layers of the biofilm. *C. albicans, Candida albicans*; PI, propidium iodide.](MMR-18-02-2017-g02){#f3-mmr-18-02-2017}

![Distribution of *Candida albicans* cell death inside the established biofilm model following treatment with blue light, as observed by confocal laser scanning microscopy (Magnification, ×400; scale bars, 50 µm). Green pixels indicate live fungi. Red pixels indicate dead fungi. Images 1--15 represent scanning images from the deepest layer of the biofilm to the superficial layers of the biofilm. PI, propidium iodide.](MMR-18-02-2017-g03){#f4-mmr-18-02-2017}

![Investigation into the effects of BL on established models of mice wound healing following inoculation with *C. albicans in vivo*. (A) Images of spread plates of the mice wound secreta obtained from the control group (*C. albicans* -, Light -), the untreated *C. albicans* group (*C. albicans* +, Light-) and the *C. albicans* group treated with 240 J/cm^2^ BL (*C. albicans* +, Light +) at 0, 1, 2 and 3 day time intervals. (B) Hematoxylin and eosin staining of wound tissues at day 7. Black arrow: Infiltration of inflammatory cells. (Scale bars, 100 µm). BL, blue light; *C. albicans, Candida albicans*.](MMR-18-02-2017-g04){#f5-mmr-18-02-2017}

![Effects of BL irradiation on wound healing in mice. (A) Back wounds of non-treated mice infected with *C. albicans*, BL-treated mice infected with *C. albicans* and the negative control group at 0, 3, 7, 10 and 14 day time intervals. (Scale bar, 1 cm). (B) Quantification of the topical wound healing rate. Data are presented as the means ± standard deviation. (C) Duration of time taken for entire wound closure. \*P\<0.05, \*\*P\<0.01. BL, blue light; *C. albicans, Candida albicans*, D, day.](MMR-18-02-2017-g05){#f6-mmr-18-02-2017}

###### 

Energy fluencies used in the present study.

  Scenario                   Irradiance (mW/cm^2^)   Illumination time (sec)    Energy fluencies (J/cm^2^)
  -------------------------- ----------------------- -------------------------- ----------------------------
  Planktonic *C. albicans*   60                      200, 1,000, 2,000, 4,000   12, 60, 120, 240
  Biofilm *C. albicans*      60                      4,000                      240
  *C. albicans* in wound     60                      4,000                      240

*C. albicans, Candida albicans*.
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